Glenn P. Sblendorio
2009 - Medicines
In 2009, Glenn P. Sblendorio earned a total compensation of $1M as President and Chief Financial Officer at Medicines, a 38% decrease compared to previous year.
Compensation breakdown
| Bonus | $201,710 |
|---|---|
| Option Awards | $92,628 |
| Salary | $434,534 |
| Stock Awards | $277,039 |
| Other | $1,794 |
| Total | $1,007,702 |
Sblendorio received $434.5K in salary, accounting for 43% of the total pay in 2009.
Sblendorio also received $201.7K in bonus, $92.6K in option awards, $277K in stock awards and $1.8K in other compensation.
Rankings
In 2009, Glenn P. Sblendorio's compensation ranked 4,442nd out of 9,885 executives tracked by ExecPay. In other words, Sblendorio earned more than 55.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,442 out of 9,885 | 55th |
Division Manufacturing | 1,579 out of 3,690 | 57th |
Major group Chemicals And Allied Products | 306 out of 866 | 65th |
Industry group Drugs | 184 out of 638 | 71st |
Industry Pharmaceutical Preparations | 145 out of 446 | 68th |
Source: SEC filing on April 27, 2012.
Sblendorio's colleagues
We found five more compensation records of executives who worked with Glenn P. Sblendorio at Medicines in 2009.
2009
Clive Meanwell
Medicines
Chief Executive Officer
2009
John Kelley
Medicines
Chief Operating Officer
2009
Paul Antinori
Medicines
General Counsel
2009
William O'Connor
Medicines
Chief Accounting Officer
2009
Catharine Newberry
Medicines